Stayble Therapeutics AB (STABL) — Financial Flexibility Index
Stayble Therapeutics AB (STABL) has a Financial Flexibility Index of 3.17x as of December 2025. Free cash flow of Skr5.38 Million (operating CF Skr-1.34 Million minus capex Skr6.72 Million) represents 3% of total liabilities (Skr1.70 Million). Check Stayble Therapeutics AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Stayble Therapeutics AB Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Stayble Therapeutics AB across 10 annual periods. For the full cash flow conversion analysis, see Stayble Therapeutics AB (STABL) cash flow conversion.
Annual Financial Flexibility Index for Stayble Therapeutics AB (2016–2025)
Year-by-year free cash flow to debt coverage for Stayble Therapeutics AB. Explore STABL cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-6.72 Million | Skr1.70 Million | ▲ +100.0% |
| 2024 | -6.15x | Skr-14.67 Million | Skr-14.67 Million | Skr2.38 Million | ▼ -35.8% |
| 2023 | -4.53x | Skr-23.54 Million | Skr-23.54 Million | Skr5.19 Million | ▲ +29.6% |
| 2022 | -6.44x | Skr-24.89 Million | Skr-24.89 Million | Skr3.87 Million | ▼ -156.0% |
| 2021 | -2.51x | Skr-9.63 Million | Skr-9.63 Million | Skr3.83 Million | ▲ +74.3% |
| 2020 | -9.80x | Skr-23.98 Million | Skr-23.98 Million | Skr2.45 Million | ▼ -33999.6% |
| 2019 | 0.03x | Skr289.39K | Skr289.39K | Skr10.01 Million | ▲ +101.0% |
| 2018 | -2.87x | Skr-5.42 Million | Skr-5.42 Million | Skr1.89 Million | ▼ -400.9% |
| 2017 | -0.57x | Skr-694.20K | Skr-2.62 Million | Skr1.21 Million | ▼ -127.0% |
| 2016 | 2.12x | Skr2.33 Million | Skr-1.39 Million | Skr1.10 Million | — |